Feedback / Questions
Somatuline LA (lanreotide suspension intramuscular) - Ipsen, Teijin
Somatuline: Patent expiry in December 2021
(36th Annual J.P. Morgan Healthcare Conference, Ipsen)
Jan 11, 2018
Patent
•
Neuroendocrine Tumor • Oncology • Solid Tumor
https://jpmorgan.metameetings.net/events/healthcare18/sessions/13523-ipsen-sa/presentation_slides
Jan 11, 2018
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious